Analysis of research and development strategy of new traditional Chinese medicine injectionsLIN Hong-mei, ZHOU Gang, WANG Ting897-902
Viewing the intellectual property protection of independent innovative drugs from the growth process of butylphthalideZHANG Xi, LI Lin, ZHOU Wen-ting903-907
Pharmacological action and clinical evaluation of thrombopoietin receptor agonist avatrombopagYU Li-ting, LIU Yuan, SHI Ai-xin908-912
Toxicity studies of alcohol precipitation from extracts of Radix sophorae tonkinensis after single dose administraion in mice and 28 days repeated dose administraion in ratsXU Zhen, SUN Jia-bin, SHAO Zhen, ZHANG Ze-an, DENG Zhong-ping913-920
Advances in study on adverse reactions of anti-tumor immune checkpoint inhibitorsQIAN Yi-min, LI Hua, MA Jing921-925
Effects of morinda officinalis oligose on plasma IL-6 and TNF-α levels in patients with depressionMU Yong-gang, DENG Shuo, ZHANG Su-zhen, GONG Xiao-yun, LI Ling-zhi, GUO Li-hua, SHI Ying, MI Wei-feng, ZHANG Hong-yan926-929
Advances in the monoclonal antibodies against calcitonin gene-related peptide for preventing migraineHOU Min, CHEN Jian-hong930-934
Hirshfeld surface and structure analysis of co-crystal of fluconazoleXING Cheng, WANG Xue, HU Kun, ZHANG Li, L(U) Yang935-940
Technical risk evaluation of the preclinical animal experiments of monoclonal antibody drugsLIU Dan-dan, CHEN Yu-wen941-947
Research progress of MAPK signaling pathway for multidrug resistance in tumorsCHAI Dong-ya, YUAN Jia-qi, ZHOU Yi-ping948-953